UFP TECHNOLOGIES INC
Reads like this one publish minutes after the filing lands on EDGAR. Get them as JSON over the API or inside your AI agent over MCP.
No enriched coverage for $UFPT in the last 7 days.
UFP Technologies director Marc D. Kozin sold 6,975 shares in two transactions, averaging $304.52 per share, totaling $2.13M. Kozin now owns 21,112 shares. The sales were reported in an SEC Form 4 filing.
KOZIN MARC D sold 7,000 shares of UFP TECHNOLOGIES INC (UFPT) at an average of $304.50 ($303.97–$305.07, $2.13M total) across 2 trades on 2026-08-25.
Hudson Symeria sold 1,926 shares of UFP TECHNOLOGIES INC (UFPT) at $324.58 ($0.63M total) on 2026-08-14.
Recent UFPT coverage spans insider activity, earnings and financial news.
In the last 30 days, UFPT insiders filed 13 SEC Form 4 transactions — no purchases and 13 sales ($12.6M). The most active reporter was BAILLY R JEFFREY, Executive Chairman, with 7 filings.
UFP Technologies director Marc D. Kozin sold 6,975 shares in two transactions, averaging $304.52 per share, totaling $2.13M. Kozin now owns 21,112 shares. The sales were reported in an SEC Form 4 filing.
The insider sale may signal reduced confidence, potentially pressuring the stock short term.
This is a routine insider open-market sale under a Form 4, with no 10b5-1 plan cited, so it may slightly affect sentiment but is not a fundamental catalyst by itself.
Routine insider sale with no stated 10b5-1 plan; may modestly affect sentiment but is not a fundamental catalyst by itself.
The filing is a routine insider sale with no stated 10b5-1 plan and zero shares remaining, but it does not provide new fundamentals.
alphai scores every news story that mentions UFPT with an AI model for sentiment and relevance, and aggregates insider trades from UFP TECHNOLOGIES INC's SEC EDGAR Form 4 filings. Figures refresh continuously.
UFP Technologies director Marc D. Kozin sold 6,975 shares in two transactions, averaging $304.52 per share, totaling $2.13M. Kozin now owns 21,112 shares. The sales were reported in an SEC Form 4 filing.
1 min readKOZIN MARC D sold 7,000 shares of UFP TECHNOLOGIES INC (UFPT) at an average of $304.50 ($303.97–$305.07, $2.13M total) across 2 trades on 2026-08-25.
1 min readHudson Symeria sold 1,926 shares of UFP TECHNOLOGIES INC (UFPT) at $324.58 ($0.63M total) on 2026-08-14.
1 min readFELDMANN CYNTHIA L sold 1,000 shares of UFP TECHNOLOGIES INC (UFPT) at $324.26 ($0.32M total) on 2026-08-13.
2 min readBAILLY R JEFFREY (Executive Chairman) sold 13,011 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $316.13 ($315.53–$317.27, $4.11M total) across 3 trades on 2026-08-10.
1 min readUFP Technologies (UFPT) reported Q2 2026 net sales of $174 million, up 15.1%, with organic sales growth of 12.4%. Adjusted EPS rose 16.8% to $2.92 and gross margin increased to 29.3%. Adjusted EBITDA was $36.4 million. Management cited MedTech strength, low leverage under 1x, and an acquisition pipeline of 5 to 10 opportunities.
6 min readBAILLY R JEFFREY (Executive Chairman) sold 15,695 indirectly-held shares of UFP TECHNOLOGIES INC (UFPT) at an average of $318.38 ($315.06–$320.05, $5.00M total) across 4 trades over 2026-08-06 to 2026-08-07.
2 min readHolt Jason (Vice President) sold 1,100 shares of UFP TECHNOLOGIES INC (UFPT) at $317.00 ($0.35M total) on 2026-08-06.
1 min readUFP Technologies (NASDAQ: UFPT) shares rose about 24% by 2 p.m. ET after the company reported strong Q2 results. UFP said sales grew 15%, adjusted EPS rose 17%, and revenue increased 15% to its five largest customers. The company also reported 12% organic growth and 20% growth in its core medtech unit, and is monitoring tuck-in acquisitions.
4 min readBiotech stocks hit 52-week highs Aug 4, 2026 after Q2 results or regulatory updates. UFP Technologies (UFPT) rose over 25% to $338.70, reporting Q2 net income $20.9M and sales $174M. InfuSystem (INFU) gained 33% to $12.49 on $36.9M Q2 revenue and 2026 guidance. Replimune (REPL) jumped to $13.86 after a favorable BLA opinion. SOPHiA (SOPH) rose to $6.98 with $23.3M Q2 revenue and 2026 outlook. Parabilis (PBLS) reached $36.69.
6 min read
